These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 3487046)

  • 1. Positron emission tomography in Alzheimer's disease.
    Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical abnormalities in Alzheimer's disease.
    Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
    Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography.
    Rumsey JM; Duara R; Grady C; Rapoport JL; Margolin RA; Rapoport SI; Cutler NR
    Arch Gen Psychiatry; 1985 May; 42(5):448-55. PubMed ID: 3872650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
    Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
    J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia.
    Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H
    Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
    Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
    Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements.
    McKeith IG; Bartholomew PH; Irvine EM; Cook J; Adams R; Simpson AE
    Br J Psychiatry; 1993 Nov; 163():597-603. PubMed ID: 8298827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
    Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
    J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
    Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
    Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
    Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
    Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
    Kumar A; Schapiro MB; Haxby JV; Grady CL; Friedland RP
    J Psychiatr Res; 1990; 24(2):97-109. PubMed ID: 2213642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in degenerative disorders of the dopaminergic system.
    Karbe H; Holthoff V; Huber M; Herholz K; Wienhard K; Wagner R; Heiss WD
    J Neural Transm Park Dis Dement Sect; 1992; 4(2):121-30. PubMed ID: 1571076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
    Friedland RP; Budinger TF; Koss E; Ober BA
    Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis.
    Santens P; De Bleecker J; Goethals P; Strijckmans K; Lemahieu I; Slegers G; Dierckx R; De Reuck J
    Eur Neurol; 2001; 45(1):19-27. PubMed ID: 11150836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
    Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
    Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.